Urenco Annual Report 2022

Financial statements Notes to the Consolidated Financial Statements continued For the year ended 31 December 2022 35. Events after the statement of financial position date As of 8 March 2023, no other material structural changes or business events have occurred that might serve to alter any of the disclosures contained in the 2022 financial statements. 36. Related party transactions Balances and transactions between the Company and its subsidiaries, which are related parties, have been eliminated on consolidation and are not disclosed in this note. Transactions between the Company and its subsidiaries are disclosed in the Company’s separate financial statements. Transactions with the Urenco pension scheme are detailed in note 32. During the year, Group companies entered into the following transactions with the following related parties who are not members of the Group: Sales of goods and services Purchases of assets, goods and services Amounts owed by related parties Amounts owed to related parties Year ended 31/12/22 €m Year ended 31/12/21 €m Year ended 31/12/22 €m Year ended 31/12/21 €m 31/12/22 €m 31/12/21 €m 31/12/22 €m 31/12/21 €m BEIS 30.4 28.4 - - 2.8 4.4 - - E.ON - - 11.7 14.3 - - - - RWE - - 0.4 0.3 - - - - ETC (i) - - 80.1 65.6 2.8 0.1 60.6 60.7 (i) These amounts are 100 % of the sales/purchases and amounts due to Enrichment Technology Company Limited. The Department for Business, Energy & Industrial Strategy (BEIS), E.ON SE (E.ON) and RWE AG (RWE) are all related parties of the Group because of their indirect shareholdings in Urenco Limited. The amounts reported under BEIS include transactions with the NDA. Enrichment Technology Company Limited is a related party due to the Group’s 50% shareholding in the joint venture. Sales of goods and services to related parties and purchases of assets, goods and services from them were made under the Group’s normal trading terms. The amounts outstanding are unsecured and will be settled in cash. No guarantees have been given or received. No provisions have been made and no expense incurred for doubtful debts in respect of the amounts owed by related parties. The Enrichment Technology Company Limited pension scheme is administered as part of the Urenco pension scheme. Included in Urenco’s share of results of Joint Venture and Investments is 50% of the Enrichment Technology Company Limited Income Statement charges and liabilities arising from retirement benefit obligations. Included in the amounts recognised in the share of results of joint venture in respect of the defined benefit schemes is a charge of €0.4 million relating to the Joint Venture (2021: €0.4 million). Included in the share of net assets of the Joint Venture as a recognised liability is €15.1 million relating to the defined benefit pension obligations of the Joint Venture (2021: €20.6 million), and €4.0 million is recognised as an asset relating to the surplus of the Joint Venture (2021: €nil). During the year, Group companies contributed €18.6 million (2021: €14.3 million) for the benefit of employees into post-employment benefit plans. Remuneration of key management personnel The remuneration of the Directors, who are the key management personnel of the Group, is set out below in aggregate for each of the categories specified in IAS 24 Related Party Disclosures. Further information about the remuneration of individual Directors is provided in the Remuneration report on page 74. Year ended 31/12/22 €m Year ended 31/12/21 €m Short term employee benefits 3.2 2.9 Long term employee benefits 1.4 0.8 Total 4.6 3.7 Directors’ transactions No Director has ever had a loan from the Company or any other transaction with the Company other than remuneration for their services as a Director, as detailed in the Remuneration report on page 73. 161 Urenco Annual report and accounts 2022 Financial statements 03